Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.71 |
| ▸ | GFER | P55789 | 1/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.57 |
| ▸ | LMNA | P02545 | 3/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.57 |
| ▸ | STAT3 | P40763 | 1/20 | 0.57 |
| ▸ | DHODH | Q02127 | 1/20 | 0.55 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.55 |
| ▸ | ME2 | P23368 | 1/20 | 0.54 |
| ▸ | ME1 | P48163 | 1/20 | 0.54 |
| ▸ | ME3 | Q16798 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29750310 | 0.84 | MEN1 (1.00) | MEN1KMT2AGFERCYP3A4KDM4E | |
| SCHEMBL6830501 | 0.83 | KMT2A (0.76) | MEN1KMT2AGFERCYP3A4KDM4E | |
| SCHEMBL419079 | 0.82 | MEN1 (0.74) | MEN1KMT2AGFERCYP3A4KDM4E | |
| SCHEMBL1897930 | 0.81 | DHODH (0.74) | KMT2AKDM4ELMNASMN1; SMN2PDE10A | |
| SCHEMBL15904177 | 0.80 | DHODH (0.76) | KMT2AKDM4ELMNASMN1; SMN2PDE10A | |
| SCHEMBL6350942 | 0.79 | GFER (0.70) | MEN1KMT2AGFERKDM4ESMN1; SMN2 | |
| SCHEMBL6833895 | 0.79 | SMN1; SMN2 (0.55) | MEN1KMT2AKDM4ELMNASMN1; SMN2 | |
| SCHEMBL1899905 | 0.79 | KDM4E (0.69) | MEN1KMT2AKDM4ELMNASMN1; SMN2 | |
| SCHEMBL1900304 | 0.79 | HSD17B10 (0.64) | MEN1KMT2AKDM4ELMNASMN1; SMN2 | |
| SCHEMBL6834280 | 0.78 | NR1H4 (0.54) | MEN1KMT2AGFERCYP3A4KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | GABRD, GABBR1, GABRA1 | MEN1 4132/4885KMT2A 2853/4885GFER 900/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.